Visit COVID-19 resources

[Skip to Content]

Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data – (Eye Journal)

16 December 2019

This news item is available to RCOphth members only, please log in below to access.

Members Login